as 03-13-2025 4:00pm EST
Stocks
Basel Medical Group Ltd provides general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, as well as neurosurgical treatments. Key revenue is generated from Singapore.
| Founded: | 2001 | Country: | Singapore |
| Employees: | N/A | City: | N/A |
| Market Cap: | 75.9M | IPO Year: | 2025 |
| Target Price: | N/A | AVG Volume (30 days): | 392.6K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.09 | EPS Growth: | 16.23 |
| 52 Week Low/High: | $3.75 - $5.40 | Next Earning Date: | 01-01-0001 |
| Revenue: | $7,428,776 | Revenue Growth: | 3.32% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
The information presented on this page, "BMGL BASEL MEDICAL GROUP LTD - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.